Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

124.05
Delayed Data
As of 4:00pm ET
 +0.08 / +0.06%
Today’s Change
94.42
Today|||52-Week Range
127.64
+7.17%
Year-to-Date

Today’s Trading

Previous close123.97
Today’s open124.21
Day’s range123.20 - 124.33
Volume3,544,305
Average volume (3 months)3,848,227
Market cap$96.4B
Dividend yield--
Data as of 4:00pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)+28.35%
Earnings growth (this year)+21.46%
Earnings growth (next 5 years)+22.00%
Revenue growth (last year)+22.70%
P/E ratio49.8
Price/Sales8.51
Price/Book14.63

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline+0.12+0.29%
BMYBristol-Myers Squibb+0.38+0.68%
----
LLYEli Lilly and Co+0.73+0.90%
Data as of 4:02pm ET, 04/28/2017

Financials

Last reporting dateApril 27, 2017
EPS forecast (this quarter)$1.63
Annual revenue (last year)$10.9B
Annual profit (last year)$2.0B
Net profit margin18.30%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark J. Alles
President &
Chief Operating Officer
Scott Andrew Smith
Corporate headquarters
Summit, New Jersey

Forecasts